HHS Tosses FDA’s Unapproved Drugs Initiative For Pricing Reasons

By Beth Wang / November 20, 2020 at 8:51 PM
In an unexpected move, President Donald Trump on Friday (Nov. 20) announced the administration will eliminate FDA’s Unapproved Drugs Initiative through which the agency has tried to remove from the market any unapproved drugs. Trump said the program is misguided and has been exploited by drug companies that obtain market exclusivity on their drugs once the older versions are pulled from the market and then raise prices of the newly approved drugs. At issue is a program launched in 2006...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.